Published in Neurology on September 25, 2015
Multi-modal Neuroimaging in Alzheimer's Disease (IMAP+) | NCT01638949
Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging. Curr Opin Neurol (2016) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res (1990) 14.82
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc (2002) 9.81
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol (2005) 3.95
Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol (2007) 3.19
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol (2010) 2.25
Association of lifetime cognitive engagement and low β-amyloid deposition. Arch Neurol (2012) 2.20
Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci (2009) 1.89
Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci (2012) 1.58
Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci (2013) 1.54
Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Arch Neurol (2012) 1.52
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia. J Neurosci (2012) 1.48
Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology (2013) 1.32
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med (2008) 1.20
Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders. Neuroimage (2013) 1.08
Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease. Arch Neurol (2004) 1.05
Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. J Neurosci (2014) 1.03
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease. Alzheimers Res Ther (2013) 0.99
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Mol Psychiatry (2012) 0.98
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers. J Alzheimers Dis (2011) 0.96
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med (2013) 0.92
How can elderly apolipoprotein E ε4 carriers remain free from dementia? Neurobiol Aging (2012) 0.91
Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord (2013) 0.91
Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative. Neurobiol Aging (2011) 0.89
Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Res (2013) 0.88
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations. Neuropsychol Rev (2014) 0.86
Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. Int J Geriatr Psychiatry (2012) 0.85
Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan. Neuropsychol Rev (2014) 0.85
Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels. J Alzheimers Dis (2013) 0.84
[Clinical evaluation of memory]. Rev Neurol (Paris) (1998) 0.78
[Examination and memory]. Rev Prat (1991) 0.77